ROIV

#501
Roivant Sciences Ltd. Common Shares
28.9400
+3.25%
セクター:
ベース:
利益通貨:
日中レンジ
28.9400
28.9400
1年のレンジ
18.2700
29.2000
1日の変化
+3.25%
月次変化
+28.91%
6か月変化
+58.06%
1年の変化
+58.06%
以前の終値
28.0300
Open
28.9400
Bid
Ask
Low
28.9400
High
28.9400
ボリューム
275
Open full chart

Financials

Overview 明細書 Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q3, 24 TTM

Roivant Sciences Ltd

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

ニュース